Researchers Receive NIH Funds for Adjuvant Research to Boost Coronavirus Vaccines
Georgia Institute of TechnologyResearchers have received funding from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system and generate appropriate responses necessary to protect the general population against the virus.